Online citations, reference lists, and bibliographies.
← Back to Search

Prednisolone And Flurbiprofen Drops To Maintain Mydriasis During Phacoemulsification Cataract Surgery

Yusuf M. Shaikh, Simon J. Mars, C. J. Heaven
Published 2003 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Purpose: To compare the effects on the pupil of pretreatment with prednisolone 1% eyedrops, flurbiprofen 0.03% eyedrops, and sodium chloride 0.9% eyedrops in patients having phacoemulsification cataract surgery. Setting: Christopher Home Eye Unit, Royal Albert Edward Infirmary, Wigan, United Kingdom. Methods: One hundred thirty‐six white patients having phacoemulsification with no history of eye disease, antiinflammatory medication, or diabetes were enrolled in this prospective randomized double‐blind study. Patients were allocated to receive flurbiprofen 0.03%, prednisolone 1%, or sodium chloride 0.9% (placebo) eyedrops at 30‐minute intervals beginning 2 hours before surgery. All patients received cyclopentolate 1% and phenylephrine 2.5% drops preoperatively and epinephrine 1:106 intraoperatively in the intraocular irrigating solution. The pupil diameter was measured from a television screen at the preset magnification of the operating microscope immediately before the incision, at the end of nucleus emulsification, at the end of irrigation/aspiration (I/A), and at the end of surgery. One hundred twelve patients with a baseline pupil diameter of at least 6.0 mm who had uneventful phacoemulsification were analyzed. Results: The baseline pupil diameters were statistically similar. An analysis of variance did not reveal an overall significant mydriasis‐maintaining effect of prednisolone or flurbiprofen compared to the placebo at any stage of surgery (P = .16 to .37). The 95% confidence interval showed flurbiprofen to be superior to prednisolone at the end of surgery. According to the paired t test, the reduction from the baseline at the end of I/A in the prednisolone group (P = .051) and at the end of surgery in the flurbiprofen group (P = .22) was not significant. Conclusion: In the presence of epinephrine in the intraocular irrigating solution, both prednisolone 1% and flurbiprofen 0.03% failed to maintain mydriasis at the crucial steps of nuclear emulsification and cortical I/A.
This paper references
Comparison of prednisolone acetate and indomethacin for maintaining mydriasis during cataract surgery.
P. Dubé (1990)
Nonsteroidal anti-inflammatory drugs in oph-Presented at a meeting of the Saudi Ophthalmological Society
A J Flach (1993)
mydriasis during cataract surgery
(1990)
Textbook of Ocular Pharmacology. Philadelphia, versus prednisolone versus combination therapy in the PA
P S Kulkarni (1997)
10.1016/S0161-6420(00)00365-1
Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.
J. Heier (2000)
Prostaglandins, nonsteroidal anti-inflammatory agents and eye disease.
Podos Sm (1976)
matory agents in ophthalmology. Curr Opin Ophthal-788-793 mol
J Nichols (1996)
roidal anti-inflammatory drugs with and without intraoperative epinephrine on the maintenance of mydriasis during cataract surgery
H V Gimbel (1989)
Efficacy tors of surgically induced miosis
R M Duffin (1982)
10.1016/S0161-6420(96)30641-6
Pretreatment with topical diclofenac sodium to decrease postoperative inflammation.
C. W. Roberts (1996)
Textbook of ocular pharmacology
T. Zimmerman (1997)
10.1016/S0161-6420(82)34693-X
Inhibitors of surgically induced miosis.
R. M. Duffin (1982)
Topical nonsteroidal anti-inflamative inflammation
J Nichols (1996)
10.1097/00055735-199808000-00007
Topical nonsteroidal anti-inflammatory agents in ophthalmology.
J. Nichols (1998)
Prostaglandins, nonsteroidal anti-inflamma0.5% ketorolac vs 0.03% flurbiprofen in inhibition of tory agents and eye disease
SM Podos (1997)
10.1016/S0161-6420(89)32845-4
The effect of treatment with topical nonsteroidal anti-inflammatory drugs with and without intraoperative epinephrine on the maintenance of mydriasis during cataract surgery.
H. Gimbel (1989)
10.1016/S0886-3350(96)80163-5
Efficacy and tolerance of diclofenac sodium 0.1%, flurbiprofen 0.03%, and indomethacin 1.0% in controlling postoperative inflammation
M. Diestelhorst (1996)
The effect of treatment with topical nonstemology
HV Gimbel (1996)
Efficacy tors of surgically induced miosis. Ophthalmology 1982; and tolerance of diclofenac sodium 0.1%, flurbiprofen 89:966–997; discussion by SM Poder, 978–979 0.03%, and indomethacin
RM Duffin (1982)
10.1097/00004397-199303340-00003
Nonsteroidal Anti-inflammatory Drugs in Ophthalmology
A. Flach (1993)
Nonsteroidal anti-inflammatory drugs in ophPresented at a meeting of the Saudi Ophthalmological Society, Riyadh, thalmology
AJ Flach (1993)
Comparison of Ophthalmology
P Dubé (2000)
Steroids in ocular therapy
PS Kulkarni (1997)
10.1001/ARCHOPHT.1997.01100160289004
Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery.
K. Solomon (1997)
10.1016/B978-1-4557-5969-9.00011-5
Nonsteroidal antiinflammatory drugs.
C. Mcilwraith (1981)



This paper is referenced by
Effect of Preoperative Use of Nepafenac and Flurbiprofen Eye Drops In Maintaining Mydriasis during Small Incision Cataract Surgery
D. Pradeep (2019)
10.1002/jps.24153
Ocular delivery of flurbiprofen based on Eudragit(®) E-flurbiprofen complex dispersed in aqueous solution: preparation, characterization, in vitro corneal penetration, and ocular irritation.
D. Quinteros (2014)
10.1007/s00347-017-0446-6
Bewertung der methodischen Qualität publizierter RCTs in der Kataraktchirurgie
C. Baulig (2017)
10.1080/03639045.2016.1275669
Freeze drying optimization of polymeric nanoparticles for ocular flurbiprofen delivery: effect of protectant agents and critical process parameters on long-term stability
Gladys Rosario Ramos Yacasi (2017)
Efficacy of Nepafenac 0.1% in Maintaining Mydriasis during Phacoemulsification Surgery -
Sajjad Ali Surhio (2013)
10.18579/JPCRKC/2012/11/1/79336
A Prospective, Randomized Controlled Study to Evaluate the Efficacy of Topical Flurbiprofen in Maintaining Intraoperative Mydriasis during Small Incision Cataract Surgery
R. Priyalatha (2012)
10.1080/03639045.2016.1275669
Freeze drying optimization of polymeric nanoparticles for ocular flurbiprofen delivery: effect of protectant agents and critical process parameters on long-term stability.
Gladys Rosario Ramos Yacasi (2017)
10.5455/2319-2003.IJBCP20150217
A study on effect of pre-operative topical prednisolone acetate, nepafenac and placebo, on intraoperative mydriasis and its sustenance during cataract surgery: a randomized trial -
S. Sethi (2015)
10.4103/0301-4738.109521
Phacoemulsification without preoperative topical mydriatics: Induction and sustainability of mydriasis with intracameral mydriatic solution
S. Gupta (2014)
10.2174/2211738503666150630185230
Design and Ocular Tolerance of Flurbiprofen Loaded Nanosuspension
Bhavani Boddeda (2015)
10.14260/JEMDS/2017/689
COMPARISON OF PREOPERATIVE TOPICAL NEPAFENAC (0.1%), FLURBIPROFEN (0.03%) AND KETOROLAC (0.4%) EYE DROPS IN MAINTAINING MYDRIASIS DURING PHACOEMULSIFICATION- A RANDOMISED, DOUBLE-BLIND STUDY
S. Mushrif (2017)
10.2147/OPTH.S4820
Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac
G. Cervantes-Coste (2009)
10.1016/j.jcrs.2018.02.027
Medical and surgical management of the small pupil during cataract surgery.
S. Al-Hashimi (2018)
10.4155/tde.15.73
Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.
R. Pignatello (2015)
10.1088/0957-4484/22/4/045101
Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
E. Gonzalez-Mira (2011)
10.3928/1081597X-20161206-06
Effect of Topical Nonsteroidal Anti-inflammatory Drugs on Pupillary Size During Uncomplicated Cataract Surgery.
Alejandro Rodriguez-Garcia (2017)
10.1016/j.ejpb.2016.08.001
Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation.
S. Doktorovová (2016)
10.1016/j.jcrs.2009.10.049
Pupil dilation using a standard cataract surgery regimen alone or with atropine 1.0% pretreatment: Prospective comparative evaluation
J. Narváez (2010)
10.1016/j.colsurfb.2010.07.029
Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
E. Gonzalez-Mira (2010)
10.4103/0301-4738.98705
Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: A randomized trial
F. Zanetti (2012)
Safety and efficacy of intracameral mydriatics in cataract surgery
B. Lundberg (2008)
10.1177/1060028015574593
Comparing the Efficacy of Ophthalmic NSAIDs in Common Indications
D. Wilson (2015)
Efeito dos antiinflamatórios tópicos acetato de prednisolona 1%, nepafenaco 0.1% e cetorolaco de trometamina 0.4% na manutenção da midríase intra-operatória em facectomias ; : estudo clnico aleatorizado
F. Zanetti (2011)
Semantic Scholar Logo Some data provided by SemanticScholar